VariZIG for Prophylaxis After Exposure to Varicella
The US manufacturer of varicella zoster immune globulin (VZIG; Massachusetts Public Health Biologic Laboratories, Boston, MA) recently discontinued its production. A Canadian formulation, VariZIG (Varicella Zoster Immune Globulin [Human] - Cangene Corporation, Winnipeg) is now available in the US under an investigational new drug application expanded access protocol....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: VariZIG for Prophylaxis After Exposure to Varicella
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1241
Article Code: 1241d
Date: August 14, 2006
Volume: 48
Pages: 69-70
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1241
Article Code: 1241d
Date: August 14, 2006
Volume: 48
Pages: 69-70
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)